Myths and mysteries surrounding bacillus calmette-guérin therapy for bladder cancer
Kamat AM1, Porten S2. Eur Urol. 2014 Feb;65(2):267-9. doi: 10.1016/j.eururo.2013.10.016. Epub 2013 Oct 26.

Author information

1Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org. 2Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Abstract

Intravesical therapy with bacillus Calmette-Guérin has proven effects for reducing recurrence, progression, and death from non-muscle-invasive bladder cancer. These advantages are seen mainly when appropriate maintenance therapy is used for 1-3 years, in the context of appropriate patient selection, tumor management, and symptom support for potential side effects.